Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

Libtayo in the U.S. grew 21% compared to ... 3 program are expected in the second half of this year. Our unique mechanism of action provides more complete C5 inhibition than observed with other ...

Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar's(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been ...

The other big challenge is, despite having a variety of different therapies that we can choose, a variety of different mechanisms of action, we don’t have the ability to pinpoint the right drug ...

and act via a previously unknown mechanism. In the newly published study, researchers led by Dr. Jennifer Herrmann and Prof. Rolf Müller uncovered the novel mode of action of chlorotonils.

technology and identified structurally novel lysine-targeting covalent inhibitors with diverse mechanisms of action. The team ...

This direct inhibition of DUBs, coupled with the known production of ROS by Ruvidar, are an exciting new combination of the mechanisms of action of the effects that Ruvidar has on cancer cells ...

Journal Editorial Report: Paul Gigot interviews Jason Riley about his new book. Derrick Bell is best known for his contributions to critical race theory—which claims that racism is embedded in ...